Mucociliary transport in the airways significantly depends on the liquid and mucin components of the airway surface liquid (ASL). The regulation of ASL water and mucin content during pathological conditions is not well understood.
Introduction
Airway surface liquid (ASL) is composed of a thin, periciliary liquid layer and an overlying mucus layer. It traps inhaled particles, microorganisms and environmental toxicants and transports them out of the airways. Despite the importance of this mucociliary clearance mechanism, its regulation under normal conditions and particularly during airway disease is poorly understood. Since inflammatory stimuli may affect ion transport at many levels, it is possible that transepithelial water flux is actively modulated during inflammation. The ability to hydrate ASL is important because an increase in mucin production alone in response to an inflammatory challenge might impair mucociliary clearance allowing mucins to accumulate in a dehydrated ASL. We speculated that airway epithelia might exhibit adaptive responses that lead to modulation of mucin content and ASL volume.
Mucins are highly glycosylated, large molecular weight glycoproteins that are the major macromolecular components of mucus. Mucins are responsible for the viscoelastic properties and hydrophilicity of the complex mucus layer that provide lubrication and protection for epithelia (39) . Thirteen mucin genes have been reported (26, 39, 53) , and M U C 2, MUC5AC and MUC5B encode for polymeric mucins that are expressed by airway epithelium and are found in airway secretions. MUC5AC and M U C 5 B were shown to be the major components of airway mucus however, all three have been shown to be increased during episodes of airway inflammation (11, 49, 52) . The biochemical and molecular mechanisms involved in the regulation of mucin synthesis under normal and pathological conditions are the subjects of intensive investigation (3, 11, 12, (28) (29) (30) 51) .
The surface clearance properties of ASL are determined not only by its mucin content, but also by its hydration. Vectorial ion transport by ciliated epithelial cells regulates ASL volume (4) . Basal transepithelial water absorption is mediated via electrogenic Na + absorption through apical epithelial Na + channels (EnaC, 4). However, airway epithelia are also capable of Ca ++ -and cyclic AMP activated-Cl -/liquid secretion mediated by Ca ++ -activated Cl -channels (CaCC) and CFTR, respectively (22) .
ASL pH may also affect airway defense (1, 2, 44, 50) . Inflammation may acidify ASL, and consequently, alkalinization of ASL by the epithelium may be an important component of airway defense. Thus, synchronous regulation of mucin production, ASL volume, and ASL pH are likely essential components of the integrated airway's defensive response to inflammation.
Inflammatory mediators that regulate mucin production, ASL volume and pH have not been reported. IL-1β, a pleiotropic and an early response cytokine in the pulmonary inflammatory cascade, is produced by many cell types, however, resident and migratory macrophages are considered to be the principal source during inflammatory episodes (10) . Since increased levels of IL-1β have been reported in inflammatory airways diseases associated with hypersecretion (34, 37, 42) , we speculated that it might be responsible for concerted regulation of both liquid and mucin metabolism. Accordingly, we designed studies to measure the effects of IL-1β on mucin production and secretion, ASL hydration, ion transport and pH regulation by human airway epithelium. For these studies, we used primary and passage-2 human airway epithelial cell cultures that mimic many of the properties of bronchial epithelium in vivo (14) . Using this system we were able to assess the direct effects of IL-1 β on the regulation of mucin secretion and fluid metabolism in pure populations of fully differentiated airway epithelial cells.
Materials and Methods
Cell culture, cell counts and immunocytochemical detection of
MUC5AC mucin.
In experiments in which mucin production and mucin gene expression were investigated, passage 2 NHTBE cells (two strains from different donors purchased from Clonetics Corp., LaJolla, CA) were seeded onto 24mm MUC5AC mucin produced by the cultures, was detected using the mouse monoclonal 45M1 antibody (Neomarkers), which has been shown to react with gastric MUC5AC (35) and MUC5AC produced by NCI-H292 cells (24) . We confirmed the specificity of the Neomarkers' antibody by comparing its reactivity with that of the MAN-5AC-1, produced and characterized by Thornton et. al. (47) against human, airway MUC5AC mucin (40) . We found that the Neomarkers' and MAN-5AC-1 antibodies have quantitatively very similar reactivity with purified MUC5AC mucin as well as with secretions from control and IL-1β stimulated NHTBE cultures.
Methods to assess the size distribution and charge density of mucins produced by NHTBE cultures have been previously reported in detail (48) .
Briefly, to characterize the secreted MUC5AC mucin from 24 hr IL-1β treated and vehicle control cultures, the apical secretions were collected in PBS (0.5 ml/well) and diluted 1:1 with 8M guanidine hydrochloride (GuHCl) and the mucin purified by two stages of CsCl density gradient centrifugation (48) . The size distribution of the mucin was determined by rate zonal centrifugation on 6-8 M Transpithelial volume flux. Two experimental protocols were used to measure the effect of IL-1β on ASL volume regulation. In both protocols, epithelia were cultured as previously described (32) Diego, CA). Data were acquired and analyzed using Acquire and Analysis (V.
1.2) software. After 15 min equilibration, amiloride (10 µM) was added to the lumenal bath, followed sequentially by bilateral isoproterenol (10 µM), lumenal UTP (100 µM), and finally serosal bumetanide (50 µM).
Ribonuclease Protection Assay (RPA) for CFTR and NnaC.
Methods for the ribonuclease protection assay with sodium channel subunit probes were as previously described (5) . A 465 bp probe corresponding to part of the N-terminus of the human C F T R sequence (accession # M28668) was prepared by PCR from a plasmid template containing a full-length CFTR cDNA using the following primers: C F T R 75F Measurements were highly accurate and reproducible within ± 0.01 pH units. 
Data presentation and analysis

Results
The effects of IL-1β β β β on MUC5AC and MUC5B mucin secretion.
Increased levels of IL-1 β have been reported to be present in BAL from patients with ongoing airway inflammatory disease (34) . In order to determine the effect of IL-1 β on mucin secretion, well differentiated, NHTBE cultures ( Fig   1) were exposed to IL-1β (2.5 ng/ml) for twenty-four hours. As seen in Fig 2A, IL-1β treated cultures secreted 2-3-fold more MUC5AC mucin than vehicle treated controls. MUC5B mucin secretion was not significantly altered ( determine whether IL-1β treatment caused differences in charge densities of secreted MUC5AC mucin, the mucin was reduced and carboxymethylated and subjected to anion-exchange chromatography on Mono Q columns (48) . These studies showed that the charge density for MUC5AC mucin in IL-1β treated cultures was similar to that in vehicle control cultures (Fig. 2C ).
Dose and time dependent stimulation of MUC5AC secretion by IL-1β β β β. . . .
Twenty-four hour treatment of NHTBE cultures with IL-1β increased the levels of secreted MUC5AC in a dose dependent manner (see Fig. 3A ).
Concentrations of IL-1β greater than 2.5 ng/ml had no increased effect. To determine how rapidly IL-1β induced MUC5AC hypersecretion, cultures were treated with IL-1β (2.5 ng/ml) for up to 72 hrs. As seen in Fig. 3B , secreted To determine whether IL-1β was acting as a secretagogue selectively via exocytosis, cultures were treated with IL-1β (0 or 2.5 ng/ml) for 24 hrs after which time apical secretions and cell lysates were collected separately from individual wells and the amounts of MUC5AC mucin was determined. As seen in prevented the IL-1β induced increase in mucin production (data not shown).
In two additional experiments the contents of the entire cultures (cells and extracellular material) were collected and assayed for MUC5AC mucin. As seen in Fig 4B, following 24 hours of IL-1β treatment, the amount of MUC5AC mucin was increased approximately 3-fold over sham treated controls.
The effect of IL-β β β β treatment on MUC5AC mRNA levels.
To determine whether IL-1β stimulation of MUC5AC mucin production was regulated at the level of mRNA, we collected total RNA from triplicate, individual cultures treated for twenty-four hours with IL-1β (0 and 2.5 ng/ml) and the levels of MUC5AC mRNA were determined by quantitative real time RT-PCR. As seen in Fig. 5 , MUC5AC mRNA levels were increased only at one and four hours following IL-1β treatment and returned to control levels by 8 hrs. However, the increases were not statistically significant.
The effect of IL-1β β β β on the percentage of solids in surface liquid.
To determine whether the increased MUC5AC secretion led to increased mucin concentration within ASL, we measured ASL percentage of solids in IL-1β or vehicle control treated cultures. Fig. 6A demonstrates that the percentage of solids in ASL fell significantly in response to IL-1β treatment. This observation suggested that increased mucin production was accompanied by proportionately more liquid secretion into ASL.
The effect of IL-1β β β β on the transepithelial volume flux (Jv).
To test the notion that IL-1β increased ASL volume, we assessed the effect of IL-1β exposure on transepithelial volume flux in bronchial cultures.
To confirm that liquid absorption in response to an apical liquid challenge To test for an IL-1β effect on volume absorption, cultures were exposed to an apical liquid volume (100 µl) challenge. IL-1β and vehicle treated cultures both absorbed liquid, but the rate of absorption in IL-1β treated cultures was significantly slowed (Fig. 6B) . To test for IL-1β induction of liquid secretion, we aspirated all possible liquid from culture surfaces leaving a residual liquid volume of 3 µl. Forty-eight hours following aspiration of the apical surface, the volume of apical liquid increased following IL-1β treatment but had decreased, i.e., was absorbed, in the control vehicle treated preparations (Fig. 6C ). These data are consistent with IL-1β induced secretion.
The effect of IL-1β β β β on ion transport.
Since transepithelial water flux is determined by active ion transport, we evaluated the effects of IL-1β on the bioelectric properties of bronchial cultures.
IL-1β did not affect transepithelial resistance or PD acutely within 30 minutes
(data not shown). Detailed studies of ion transport were undertaken in cultures treated with IL-1β or vehicle control for 48 hours. A representative tracing is shown in Fig. 7A . In comparison to controls, IL-1β treated cultures had an increased basal I sc . The raised basal I sc was absolutely and proportionately less amiloride sensitive, suggesting both a reduction in Na + absorption and an increase in Cl -secretion. Analysis of mean data confirmed a raised basal I sc , a reduction in amiloride sensitive I sc , and an increased amiloride insensitive I sc in IL-1β treated cultures (Fig. 7B ).
To test whether IL-1β modulated CFTR-dependent Cl -secretion, we stimulated cells with isoproterenol. The increase in I s c in response to isoproterenol was enhanced in IL-1β treated preparations, suggesting an increase in CFTR-dependent Cl -conductance (Fig. 7A, C) . To test whether a Ca ++ -activated Cl -conductance was also increased by IL-1β, we exposed cultures to apical UTP. The increase in I sc was somewhat greater in IL-1β treated versus control preparations (Fig. 7A, C (Fig. 7A ).
The effect of IL-1β β β β on CFTR and ENaC mRNA levels.
IL-1β effects on isoproterenol-stimulated and amiloride sensitive currents could reflect transcriptional upregulation of CFTR and down regulation of ENaC respectively. Therefore, we quantified mRNA levels for CFTR and the three subunits of ENaC in vehicle control and IL-1β treated cultures. IL-1β significantly increased CFTR mRNA levels but did not affect ENaC mRNA levels. (Fig. 8 A, B) The effect of IL-1β β β β on pH and ion composition of ASL.
We measured pH and ionic composition of apical liquid from IL-1β and vehicle control treated cultures. Time dependent HCO 3 -depletion and ASL acidification were detected in vehicle control exposed cultures, as previously reported (7, 41) . In contrast, pH remained at 7.4 in IL-1β treated cultures, reflecting a constant [HCO 3 -] (Fig. 9A,B) . Although the apical liquid remained isotonic in both control and IL-1β treated cultures following 24 hours of treatment (data not shown), ASL Cl -was significantly elevated in control as compared to IL-1β treated preparations (Fig. 9C) 
Discussion
The airways are continually exposed to inhaled pathogens, particulates and environmental toxicants. Mucociliary clearance is a major innate defense mechanism to prevent airway damage from these exposures ( Previous studies using explant cultures of gastrointestinal lining showed that IL-1β stimulated mucin exocytosis (8) . Here we report that IL-1β treatment increased MUC5AC mucin production and secretion by human airway epithelia in a time and dose dependent manner. Interestingly, MUC5B mucin secretion was not increased by IL-1β treatment. MUC5AC mucin production was stimulated by as little as 0.25 ng/ml of IL-1β and was increased within 8-12 hrs of IL-1β exposure (Fig. 3) . While there are no reports that cytokines alter the physicochemical properties of mucins, there have been a number of reports indicating that in airway inflammatory diseases some of these properties are altered (41) . In the present studies, no evidence was found to indicate that IL-1β altered the physicochemical properties of MUC5AC mucin.
In vivo, airway inflammation is commonly associated with goblet cell hyperplasia, increased MUC5AC mRNA levels and mucin over-production. In the studies reported here using normal human bronchial cells, no increase in the number of MUC5AC mucin producing cells occured following treatment with IL-1β. However, the cytokine did increase the total (intracellular plus extracellular) amount of MUC5AC mucin per culture. With respect to mechanism of induction of MUC5AC production, IL-1β treatment did not deplete cell associated MUC5AC, as might be expected if the cytokine was acting selectively as a secretagogue (Fig. 4A) . Because IL-1β treatment resulted in an approximately three-fold increase in the total amount (intracellular plus secreted levels) per culture of MUC5AC mucin (Fig 4B) and because the protein synthesis inhibitor, puromycin, inhibited the levels of MUC5AC mucin, we concluded that in NHTBE cell cultures, the main IL-1β effect was to increase production of mucin rather than to act as a secretagogue.
Several investigators have reported that diverse inflammatory mediators increase MUC5AC mRNA levels in airway cell lines by transcriptional or posttranscriptional mechanisms (3, 4, 11, 12, (27) (28) (29) (30) . We also found this to be true using NCI-H292 cells and reported that IL-1β, TNF-α, lipopolysaccharide or neutrophil elastase increase MUC5AC expression (24) . In the present study A key aspect of this study was to determine whether the increased production of mucin was accompanied by an increase in surface liquid. We have recently shown that normal airway epithelia regulate ion transport so that they absorb liquid in times of volume excess on airway surfaces and secrete liquid when there is volume depletion (45) . Consequently, we evaluated functional consequences of IL-1β on ASL volume metabolism by two approaches. First, we asked whether ASL volume could be increased by inhibition of volume absorption. This question is probably most relevant clinically because in vivo ASL normally is transported cephalad along airway surfaces, imposing volume loads on the proximal airways (43) . IL-1β did indeed inhibit volume absorption, suggesting that IL-1β can effectively add liquid to airway surfaces by this mechanism (Fig. 6B) . Second, we asked whether airway epithelia could add liquid to "dry" airway surfaces in response to IL-1β. Our data suggest that this was also possible (Fig. 6C) .
We explored the ion transport mechanisms regulated by IL-1β. We found that IL-1β appeared to expand ASL volume by altering the balance between Na + absorption, which was inhibited, and anion secretion, which was stimulated (Figs. 6, 7) . IL-1β also appeared to prime airway epithelia to respond to secretagogues, since the anion secretory responses to isoproterenol (CFTR) and UTP (Ca ++ activated chloride conductance) were also augmented (Fig. 7) .
Increased CFTR-dependent secretion may, at least in part, reflect an increase in CFTR gene expression (Fig. 8) . The inhibition of amiloride sensitive current did not reflect reduced ENaC gene expression, but could reflect increased CFTR expression, as CFTR interacts with ENaC to inhibit Na + absorption in airway epithelia (38) , or it could reflect activation of other mechanisms that directly inhibit ENaC.
Taken together, our data indicate that airway epithelia coordinate mucin and ASL metabolism. Importantly, the expansion of ASL volume (secretion) exceeded that of mucin secretion, as indicated by the drop in % of solids ( 
